60 results on '"Preskorn, Sheldon H."'
Search Results
2. Discovery of New Transmitter Systems and Hence New Drug Targets
3. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development
4. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development
5. Use of Laboratory in Psychiatry
6. Multiple Psychiatric Medications Use in Psychiatry: How Rational Can It Be?
7. Use of Laboratory Assessments in Psychiatry
8. Factors affecting the biphasic concentration: effect relationships of tricyclic antidepressants
9. Mechanisms and Interventions in Tricyclic Antidepressant Overdoses
10. Plasma Monitoring of Antidepressants
11. Discovery and Development of Monoamine Transporter Ligands
12. Back to the Future of Neuropsychopharmacology
13. Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example
14. The History of Drug Development in Psychiatry: A Lesson in Serendipity
15. The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders
16. Post-Approval Research in Drug Development: Priorities and Practices
17. Genomics in Treatment Development
18. Drug Development for New Psychiatric Drug Therapies
19. Increased Inflammation and Treatment of Depression: From Resistance to Reuse, Repurposing, and Redesign
20. The Role of fMRI in Drug Development: An Update
21. Targeted Treatments for Fragile X Syndrome
22. Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics
23. Experimental Medicine Approaches in Early-Phase CNS Drug Development
24. The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders
25. Neurostimulation Therapies
26. Clinical Implications of the STAR*D Trial
27. Impact, Diagnosis, Phenomenology, and Biology
28. Other Antidepressants
29. Selective Serotonin Reuptake Inhibitors
30. Pharmacogenomics and Biomarkers of Depression
31. Serotonin and Norepinephrine Reuptake Inhibitors
32. Management of Late-Life Depression
33. NMDA Antagonists for Treatment-Resistant Depression
34. Role of Inflammation in Depression and Treatment Implications
35. Treatment of Depression in Women
36. Therapeutic Drug Monitoring of Antidepressants
37. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders
38. The Use of Antidepressants in Bipolar Depression
39. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?
40. Current Role of Herbal and Natural Preparations
41. Treatment-Refractory Depression
42. Selective Serotonin Reuptake Inhibitors
43. Women
44. Older Adults
45. Role of Pharmacogenetics/Pharmacogenomics in the Development of New Antidepressants
46. New Hypotheses to Guide Future Antidepressant Drug Development
47. Personality Disorders
48. Promising New Directions in Antidepressant Development
49. Bipolar Mood Disorders
50. Children and Adolescents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.